January 19, 2018 / 1:34 AM / a year ago

Plaintiffs granted subpoena of AbbVie CEO in upcoming Depakote trial

A federal judge in Illinois overseeing parts of the mass litigation over antiepileptic drug Depakote denied a request by AbbVie Inc to quash a subpoena for the unit’s chief executive to appear in an upcoming trial over allegations the drug causes birth defects.

Chief U.S. District Judge Michael Reagan in an opinion on Wednesday ruled he could not find the CEO’s testimony to be “clearly inadmissible on all grounds.”

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2DlgOdu

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below